Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
6.82
+0.06 (0.89%)
Oct 31, 2024, 4:00 PM EDT - Market closed
Serina Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue | 3.17 | 3.15 | 0.59 | 3.46 |
Revenue Growth (YoY) | 2368.87% | 433.14% | -82.93% | - |
Cost of Revenue | 4.21 | 2.39 | 1.57 | 3.8 |
Gross Profit | -1.04 | 0.77 | -0.98 | -0.33 |
Selling, General & Admin | 6.37 | 3.89 | 1.29 | 1.3 |
Operating Expenses | 6.37 | 3.89 | 1.29 | 1.3 |
Operating Income | -7.41 | -3.13 | -2.27 | -1.63 |
Interest Expense | -0.71 | -0.56 | -0.02 | -0 |
Interest & Investment Income | 0.28 | 0.28 | 0 | 0.01 |
Other Non Operating Income (Expenses) | 4.32 | 1.08 | -0.12 | 0.21 |
EBT Excluding Unusual Items | -3.51 | -2.33 | -2.41 | -1.42 |
Gain (Loss) on Sale of Investments | - | - | -0.01 | -0.01 |
Gain (Loss) on Sale of Assets | - | - | - | -0.03 |
Other Unusual Items | -3.53 | 7.6 | -0.27 | 0.19 |
Pretax Income | -7.03 | 5.27 | -2.68 | -1.26 |
Net Income | -7.01 | 5.27 | -2.68 | -1.26 |
Net Income to Common | -7.01 | 5.27 | -2.68 | -1.26 |
Shares Outstanding (Basic) | 4 | 2 | 2 | 2 |
Shares Outstanding (Diluted) | 4 | 4 | 2 | 2 |
Shares Change (YoY) | -15.81% | 86.72% | 0.01% | - |
EPS (Basic) | -1.74 | 2.30 | -1.25 | -0.59 |
EPS (Diluted) | -1.74 | 1.46 | -1.25 | -0.59 |
Free Cash Flow | -10.69 | -2.98 | -2.09 | -2.34 |
Free Cash Flow Per Share | -2.65 | -0.74 | -0.97 | -1.09 |
Gross Margin | -32.68% | 24.30% | -165.95% | -9.64% |
Operating Margin | -233.50% | -99.18% | -383.83% | -47.09% |
Profit Margin | -220.87% | 167.11% | -453.44% | -36.50% |
Free Cash Flow Margin | -337.05% | -94.53% | -352.55% | -67.41% |
EBITDA | -7.27 | -3.04 | -2.21 | -1.6 |
EBITDA Margin | -229.06% | -96.37% | - | -46.13% |
D&A For EBITDA | 0.14 | 0.09 | 0.06 | 0.03 |
EBIT | -7.41 | -3.13 | -2.27 | -1.63 |
EBIT Margin | -233.50% | -99.18% | - | -47.09% |
Revenue as Reported | 3.17 | 3.15 | 0.59 | 3.46 |
Source: S&P Capital IQ. Standard template.
Financial Sources.